|
Celiac Disease
|
0.500 |
Biomarker
|
disease |
CTD_human |
|
|
|
|
Celiac Disease
|
0.500 |
Biomarker
|
disease |
HPO |
|
|
|
|
Celiac Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
HLA-DQB1*02 allele in children with celiac disease: Potential usefulness for screening strategies.
|
31187602 |
2019 |
|
Celiac Disease
|
0.500 |
GeneticVariation
|
disease |
LHGDN |
Allele and haplotype frequencies for HLA class II (DQA1 and DQB1) loci in patients with celiac disease from Spain.
|
15120190 |
2004 |
|
Celiac Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
As expected, all CD patients had at least one of the CD-associated alleles, and the highest CD risk was indicated by the presence of the HLA-DQ2.5 heterodimer (HLA-DQA1*05-DQB1*02) with HLA-DQB1*02 in homozygosity.
|
25413104 |
2014 |
|
Celiac Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Classical CD was more frequent with a double versus single dose of the HLA-DQB1*02 allele (OR = 1.758, 95%CI: 1.148-2.692, I2 = 0.0%).
|
30763397 |
2019 |
|
Celiac Disease
|
0.500 |
Biomarker
|
disease |
LHGDN |
Gene, gut and schizophrenia: the meeting point for the gene-environment interaction in developing schizophrenia.
|
15617864 |
2005 |
|
Celiac Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Genetic predisposition to coeliac disease (CD) is determined primarily by alleles at the HLA-DQB locus, and evidence exists implicating other major histocompatibility complex-linked genes (6p21) and the CTLA4 locus on chromosome 2q33.
|
15713213 |
2005 |
|
Celiac Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Genetic predisposition to celiac disease (CD) is determined primarily by the human leukocyte antigen (HLA) genes (CELIAC1 region; 6p21), although many loci are involved in disease susceptibility.
|
17767555 |
2007 |
|
Celiac Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Higher frequencies for HLA-DQB1*02:01 (40.25 vs. 9.58%, P < 0.001) and DQB1*02:02 (20.34 vs. 5.42%, P < 0.001) were observed in patients with CD, whereas HLA-DQB1*03:01 (16.53 vs. 30.42%, P < 0.001), DQB1*05:01 (0.85 vs. 10%, P < 0.001), and DQB1*05:02 (5.51 vs. 17.92%, P < 0.001) were significantly lower, as compared with the controls.
|
23041663 |
2012 |
|
Celiac Disease
|
0.500 |
GeneticVariation
|
disease |
LHGDN |
HLA DQA1*0501 and DQB1*02 in Cuban celiac patients.
|
16916661 |
2006 |
|
Celiac Disease
|
0.500 |
GeneticVariation
|
disease |
LHGDN |
HLA DQA1-DQB1 genotypes in Bedouin families with celiac disease.
|
12039527 |
2002 |
|
Celiac Disease
|
0.500 |
Biomarker
|
disease |
LHGDN |
HLA-DQ2 and -DQ8 signatures of gluten T cell epitopes in celiac disease.
|
16878175 |
2006 |
|
Celiac Disease
|
0.500 |
Biomarker
|
disease |
BEFREE |
HLA-DQA1 and HLA-DQB1 in Celiac disease predisposition: practical implications of the HLA molecular typing.
|
23050549 |
2012 |
|
Celiac Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
HLA-DQA1 and HLA-DQB1 Alleles, Conferring Susceptibility to Celiac Disease and Type 1 Diabetes, are More Expressed Than Non-Predisposing Alleles and are Coordinately Regulated.
|
31331105 |
2019 |
|
Celiac Disease
|
0.500 |
Biomarker
|
disease |
BEFREE |
However, multivariate analysis demonstrated that patients with potential CD have a higher frequency of both HLA-DQB1*0302 and HLA-DQB1*0603 alleles and a reduced frequency of DQB1*02 homozygosity compared with patients with uncomplicated and complicated CD.
|
21694611 |
2012 |
|
Celiac Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
However, patients with type 1 diabetes who had the HLA-DQB 1*02 allele and, therefore, a higher risk for celiac disease (CD) absorbed significantly more mannitol (mean + 95% CI): 17.7% (15.2-20.2) than did those negative for this allele: 12.3% (8.2-16.4), p = 0.04.
|
12515291 |
2002 |
|
Celiac Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
In the non-CD family history group, an association between delayed disease onset and HLA-DQ8 carriage was observed (p < 0.001), besides an influence of HLA-DQB1*02 gene dosage on clinical presentation and severity of histological damage (after adjusting for age and sex, p = 0.05 and p = 0.02, respectively) and a trend towards presence of specific antibodies (p = 0.09).
|
31196071 |
2019 |
|
Celiac Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
In the present study we analysed this population to evaluate the degree of association with CD of the haplotypes and genotypes at the main HLA-DQB1 and DQA1 disease loci.
|
11929591 |
2001 |
|
Celiac Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Indeed, no differences have been found in CD risk between DQ2/β2 and DQ2/DQ2, as well as between DQ8/β2 and DQ2/DQ8, and between β2/DQX and DQ2/X.ConclusionThe HLA-DQB1*02:01 allele is present in more than 90% CD children.
|
29244800 |
2018 |
|
Celiac Disease
|
0.500 |
GeneticVariation
|
disease |
LHGDN |
Moreover, individuals with at least 1 HLA-DQB1*02 allele tend to have a more expressed clinical and histological form of celiac disease.
|
18728523 |
2008 |
|
Celiac Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Moreover, individuals with at least 1 HLA-DQB1*02 allele tend to have a more expressed clinical and histological form of celiac disease.
|
18728523 |
2008 |
|
Celiac Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Our study shows a significant gene dose effect in terms of tTGA level at diagnosis, but no significant association between HLA-DQB1*02 allele dose and the clinical outcomes in CD.
|
30779476 |
2019 |
|
Celiac Disease
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Polymorphism within the HLA-DQB1*02 promoter associated with susceptibility to coeliac disease.
|
9587738 |
1998 |
|
Celiac Disease
|
0.500 |
Biomarker
|
disease |
BEFREE |
The aim of this study was to investigate a possible correlation between the HLA-DQA1 and HLA-DQB1 genetic markers and clinical features of celiac disease.
|
12050583 |
2002 |